edrophonium has been researched along with omega-n-methylarginine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chowienczyk, PJ; Cockcroft, JR; Ritter, JM | 1 |
Chowdhary, S; Coote, JH; Marsh, AM; Townend, JN | 1 |
2 trial(s) available for edrophonium and omega-n-methylarginine
Article | Year |
---|---|
Inhibition of acetylcholinesterase selectively potentiates NG-monomethyl-L-arginine-resistant actions of acetylcholine in human forearm vasculature.
Topics: Acetylcholine; Adult; Arginine; Dose-Response Relationship, Drug; Drug Synergism; Edrophonium; Forearm; Humans; Kinetics; Methacholine Chloride; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 1995 |
Nitric oxide and cardiac muscarinic control in humans.
Topics: Adolescent; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adult; Bradycardia; Cardiotonic Agents; Cholinesterase Inhibitors; Cross-Over Studies; Edrophonium; Enzyme Inhibitors; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Male; Muscarinic Agonists; Nitric Oxide; omega-N-Methylarginine; Parasympathetic Nervous System; Phenylephrine; Receptors, Muscarinic; Single-Blind Method; Species Specificity; Sympathetic Nervous System; Vasoconstrictor Agents | 2004 |